Balance Sheet Data

Knight Therapeutics Inc. (GUD.TO)

$4.4

-0.04 (-0.90%)

Year
A/P
2017
Actual
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Projected
2023
Projected
2024
Projected
2025
Projected
2026
Projected
Total Cash 787.88703.82430.62411.34162.9920,698.2455,206.44147,246.92392,737.761,047,512.23
Total Cash (%)
Account Receivables 231036355413.481,102.832,941.467,845.4920,925.53
Account Receivables (%)
Inventories 1.221.1470.8756.5072.40299.56798.992,131.075,68415,160.40
Inventories (%)
Accounts Payable 0.540.7572.8344.5165.31279.07744.351,985.335,295.2914,123.63
Accounts Payable (%)
Capital Expenditure -0.13-3.87-2.95-20.67-224.18-183.24-488.73-1,303.55-3,476.83-9,273.43
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.